Related Experiment Video

Updated: Jul 11, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.4K

Ablation versus medical therapy for patients with atrial fibrillation: An updated meta-analysis

Fatemeh Kheshti1,2, Saeed Abdollahifard2,3, Alireza Hosseinpour1,2

  • 1Department of Cardiovascular Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Clinical Cardiology
|November 8, 2023
PubMed

Insights

Catheter ablation offers significant benefits for atrial fibrillation (AF) patients compared to medical therapy. Ablation reduces mortality, hospitalization, AF recurrence, and disease progression, while improving heart function.

Area of Science:

  • Cardiology
  • Medical Interventions

Background:

  • Atrial fibrillation (AF) management often involves medical therapy, but its long-term efficacy and impact on clinical outcomes require ongoing evaluation.
  • Comparing catheter ablation against medical management is crucial for optimizing patient care and treatment strategies in AF.

Approach:

  • A systematic review and meta-analysis of 31 studies, including 27 randomized controlled trials with 6965 patients, was conducted.
  • Data from PubMed, Scopus, Embase, and Web of Science were synthesized to compare ablation and medical therapy outcomes.
  • Key clinical outcomes analyzed included stroke, mortality, hospitalization, AF recurrence, AF progression, and left ventricular ejection fraction (LVEF).

Key Points:

  • Catheter ablation demonstrated a significant 29% reduction in all-cause mortality (RR: 0.71) compared to medical therapy.
  • Ablation led to a 57% reduction in hospitalizations (RR: 0.43) and a 53% decrease in AF recurrence (RR: 0.47).
  • Significant improvements were observed in LVEF (MD: 6.84%) and a substantial reduction in AF progression (RR: 0.11) with ablation.

Conclusions:

  • Catheter ablation appears superior to medical therapy for patients with atrial fibrillation, offering significant improvements in major clinical outcomes.
  • Ablation is associated with reduced mortality, hospitalization rates, and AF recurrence, alongside enhanced cardiac function.
  • The findings support catheter ablation as a highly effective treatment option for managing atrial fibrillation and its complications.

Keywords:
antiarrhythmic drugsatrial fibrillationcatheter ablationmedical therapy

More Related Videos

Robotic Ablation of Atrial Fibrillation11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

19.7K
Author Spotlight: Improving Lesion Contiguity in Pulmonary Vein Isolation via Proactive Esophageal Cooling05:43

Author Spotlight: Improving Lesion Contiguity in Pulmonary Vein Isolation via Proactive Esophageal Cooling

Published on: April 19, 2024

1.1K

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
16
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
24
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
9
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
751